Cargando…
Effective immuno-therapeutic treatment of Canine Leishmaniasis
BACKGROUND: Canine Leishmaniasis (CanL) caused by the L. infantum species is one of the biggest threats to the health of the South American canine population. Chemotherapeutics currently used for the treatment of CanL fail to induce a total parasite clearance while inducing numerous side effects. As...
Autores principales: | Ramos, Rafael Antonio Nascimento, Giannelli, Alessio, Fasquelle, François, Scuotto, Angelo, Betbeder, Didier |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10237639/ https://www.ncbi.nlm.nih.gov/pubmed/37216392 http://dx.doi.org/10.1371/journal.pntd.0011360 |
Ejemplares similares
-
Nasal vaccination of six squirrel monkeys (Saimiri sciureus): Improved immunization protocol against Toxoplasma gondii with a nanoparticle-born vaccine
por: Fasquelle, François, et al.
Publicado: (2023) -
Starch-based NP act as antigen delivery systems without immunomodulating effect
por: Fasquelle, François, et al.
Publicado: (2022) -
Intranasal vaccine from whole Leishmania donovani antigens provides protection and induces specific immune response against visceral leishmaniasis
por: Helou, Doumet Georges, et al.
Publicado: (2021) -
Protein delivery by porous cationic maltodextrin-based nanoparticles into nasal mucosal cells: Comparison with cationic or anionic nanoparticles
por: Lê, Minh Quan, et al.
Publicado: (2018) -
Canine visceral leishmaniasis: risk factors and spatial analysis in an endemic area of Northeastern Brazil
por: Silva, Samuel Souza, et al.
Publicado: (2023)